1. Home
  2. ANNX vs DQ Comparison

ANNX vs DQ Comparison

Compare ANNX & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$4.28

Market Cap

726.1M

Sector

Health Care

ML Signal

N/A

Logo DAQO New Energy Corp.

DQ

DAQO New Energy Corp.

N/A

Current Price

$11.68

Market Cap

692.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
DQ
Founded
2011
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
726.1M
692.2M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
ANNX
DQ
Price
$4.28
$11.68
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$17.00
★ $17.92
AVG Volume (30 Days)
★ 3.6M
552.7K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.44
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$9.89
52 Week High
$7.18
$35.01

Technical Indicators

Market Signals
Indicator
ANNX
DQ
Relative Strength Index (RSI) 56.67 53.76
Support Level $3.71 $11.37
Resistance Level $4.37 $12.48
Average True Range (ATR) 0.26 0.68
MACD 0.06 0.22
Stochastic Oscillator 73.86 59.52

Price Performance

Historical Comparison
ANNX
DQ

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: